Bought a few MUEL($251.35) for a trade. Q1 earnings should be out after the close today. The company added $120M (!) to backlog in March, according to this blurb from the annual report....
The Company remains in a strong position as 2025 begins. The manufacturing backlog on December 31, 2024, was $153.7 million,
down from the June 30, 2024, backlog of $187.3 million. This is still a record backlog for the start of a year. Strong order entry has
continued into the first quarter of 2025. This month, we received approximately $120 million of pharmaceutical market orders,
part of which we will execute in the new Springfield building. The current backlog, combined with investments in equipment and
talent, puts the Company in a strong operational and financial position.
We make a living by what we get, we make a life by what we give.
--Winston Churchill